Insider · CIK 0001346421
Charles Lee Nuzum Sr
Files at AGPU (Axe Compute Inc.). First filing -, latest -.
Charles Lee Nuzum Sr files SEC Form 4 as director at AGPU (Axe Compute Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles Lee Nuzum Sr has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | AGPU Axe Compute Inc. | AGrant or award Common Stock | +733 | $0.00 | $0 | 23,541 | 8 d ago |
| Jul 1, 2026 | AGPU Axe Compute Inc. | AGrant or award Common Stock | +2,420 | $0.00 | $0 | 22,808 | 34 d ago |
| Apr 20, 2026 | AGPU Axe Compute Inc. | AGrant or award Common Stock | +14,082 | $0.00 | $0 | 20,388 | Apr 23, 2026 |
| Sep 9, 2025 | AGPU Axe Compute Inc. | AGrant or award Common Stock | +64,680 | $0.00 | $0 | 94,587 | Sep 11, 2025 |
Questions about Charles Lee Nuzum Sr
Answered from the filings on this page, as of the latest one.
Is Charles Lee Nuzum Sr buying or selling?
Charles Lee Nuzum Sr has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles Lee Nuzum Sr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles Lee Nuzum Sr has 0.
Where does Charles Lee Nuzum Sr file Form 4?
Charles Lee Nuzum Sr has filed Form 4 at AGPU (Axe Compute Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.